- Home
- KURA vs CPAC Comparison
KURA vs CPAC Comparison
Compare KURA & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- CPAC
- Stock Information
- Founded
- KURA 2014
- CPAC 1949
- Country
- KURA United States
- CPAC Peru
- Employees
- KURA N/A
- CPAC N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- CPAC Building Materials
- Sector
- KURA Health Care
- CPAC Industrials
- Exchange
- KURA Nasdaq
- CPAC Nasdaq
- Market Cap
- KURA 561.9M
- CPAC 544.2M
- IPO Year
- KURA N/A
- CPAC 2012
- Fundamental
- Price
- KURA $7.34
- CPAC $6.15
- Analyst Decision
- KURA Strong Buy
- CPAC Sell
- Analyst Count
- KURA 13
- CPAC 2
- Target Price
- KURA $24.45
- CPAC $6.20
- AVG Volume (30 Days)
- KURA 1.5M
- CPAC 4.0K
- Earning Date
- KURA 08-07-2025
- CPAC 07-21-2025
- Dividend Yield
- KURA N/A
- CPAC 8.15%
- EPS Growth
- KURA N/A
- CPAC 26.68
- EPS
- KURA N/A
- CPAC 0.14
- Revenue
- KURA $83,279,000.00
- CPAC $572,828,408.00
- Revenue This Year
- KURA $125.04
- CPAC N/A
- Revenue Next Year
- KURA $83.75
- CPAC N/A
- P/E Ratio
- KURA N/A
- CPAC $8.67
- Revenue Growth
- KURA N/A
- CPAC 3.37
- 52 Week Low
- KURA $5.41
- CPAC $5.10
- 52 Week High
- KURA $21.57
- CPAC $6.65
- Technical
- Relative Strength Index (RSI)
- KURA 67.38
- CPAC 47.97
- Support Level
- KURA $5.45
- CPAC $6.01
- Resistance Level
- KURA $6.74
- CPAC $6.37
- Average True Range (ATR)
- KURA 0.38
- CPAC 0.14
- MACD
- KURA 0.10
- CPAC -0.03
- Stochastic Oscillator
- KURA 82.17
- CPAC 35.64
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.